Trade Repligen Corp - RGEN CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.34 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023679% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001457% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 0.1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 128.42 |
| Open | 125.81 |
| 1-Year Change | -31.13% |
| Day's Range | 125.81 - 132.59 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 1, 2025 | 128.42 | 0.84 | 0.66% | 127.58 | 128.65 | 124.57 |
| Mar 31, 2025 | 127.18 | -2.77 | -2.13% | 129.95 | 130.48 | 125.34 |
| Mar 28, 2025 | 133.29 | -2.21 | -1.63% | 135.50 | 136.92 | 130.30 |
| Mar 27, 2025 | 136.92 | -1.03 | -0.75% | 137.95 | 140.44 | 136.51 |
| Mar 26, 2025 | 139.19 | -1.19 | -0.85% | 140.38 | 141.97 | 136.50 |
| Mar 25, 2025 | 141.80 | -0.15 | -0.11% | 141.95 | 146.62 | 140.08 |
| Mar 24, 2025 | 145.00 | 5.05 | 3.61% | 139.95 | 145.43 | 139.95 |
| Mar 21, 2025 | 139.90 | 3.95 | 2.91% | 135.95 | 140.06 | 135.08 |
| Mar 20, 2025 | 139.16 | -0.79 | -0.56% | 139.95 | 143.99 | 137.81 |
| Mar 19, 2025 | 144.72 | 0.77 | 0.53% | 143.95 | 146.31 | 137.59 |
| Mar 18, 2025 | 144.23 | 3.60 | 2.56% | 140.63 | 147.44 | 138.88 |
| Mar 17, 2025 | 152.66 | 5.45 | 3.70% | 147.21 | 153.75 | 147.21 |
| Mar 14, 2025 | 150.41 | 9.46 | 6.71% | 140.95 | 150.72 | 140.95 |
| Mar 13, 2025 | 142.27 | 2.28 | 1.63% | 139.99 | 145.64 | 139.55 |
| Mar 12, 2025 | 145.30 | -3.01 | -2.03% | 148.31 | 149.04 | 141.17 |
| Mar 11, 2025 | 146.77 | 9.81 | 7.16% | 136.96 | 148.42 | 135.95 |
| Mar 10, 2025 | 136.83 | -14.29 | -9.46% | 151.12 | 151.86 | 135.66 |
| Mar 7, 2025 | 155.64 | -2.31 | -1.46% | 157.95 | 161.18 | 149.95 |
| Mar 6, 2025 | 160.04 | 6.71 | 4.38% | 153.33 | 163.25 | 153.05 |
| Mar 5, 2025 | 157.55 | 9.49 | 6.41% | 148.06 | 159.66 | 148.06 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Repligen Company profile
About Repligen Corporation
Repligen Corporation is a life sciences company that develops and commercializes bioprocessing technologies and systems that rises flexibility in the process of manufacturing biological drugs. The Company's bioprocessing business consist of four franchises, Filtration; Chromatography; Process Analytics; and Proteins. The Filtration products are used in process development and process scale (clinical and commercial) production. The Chromatography franchise includes products used in downstream purification, development, and manufacturing of biological drugs. The Process Analytics products allow end-users to make in-line absorbance measurements allowing for the determination of protein concentration in filtration, chromatography formulation and fill-finish applications. The Proteins franchise is represented by its Protein A affinity ligands, which are a critical component of Protein A chromatography resins used in downstream purification of virtually all mAb-based drugs on the market.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Repligen Corporation revenues increased 83% to $670.5M. Net income increased from $59.9M to $128.3M. Revenues reflect Product revenue - Filtration products segment increase from $174.9M to $403.5M, Product revenue - Protein products segment increase of 53% to $123.7M, Europe segment increase of 83% to $254.8M, North America segment increase of 56% to $274.9M.
Equity composition
Common Stock $.01 Par, 01/11, 40M auth., 30,787,307 issd. Insiders & strategic holders own 13.21%. PO 5/91, 2M shares @ $12.50 by Lehman Bros. Public Offering 2/94, 2.9M shares @ $6 by Lehman Brothers.
| Industry: | Medical Equipment, Supplies & Distribution (NEC) |
Building 1, Suite 100
41 Seyon Street
WALTHAM
MASSACHUSETTS 02453
US
News
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025
Coffee price forecast: 2025-2030 third-party coffee target
Coffee prices have cooled considerably in the past few months. Is a rebound in store or will they continue to fall?
09:42, 12 March 2025
The Simpsons predicted XRP to hit $589: Has the show got it right again?
Did the animated TV show predict a breakout for the XRP cryptocurrency?
11:00, 11 March 2025
Rolls-Royce share price forecast: third- party price target
Our Rolls-Royce share price forecast looks at the outlook for the FTSE 100-listed engineering company after a tough few years.
14:58, 10 March 2025
Gasoline petrol price forecast 2025-2030: Third-party price target
Discover third-party gasoline (petrol) price predictions for 2025 and beyond, with analyst targets, historical prices, and trading strategies.
10:27, 3 March 2025
USD forecast - third party data round up
The DXY hit a seven-month low in January, just a few months after a multi-decade peak in late September.
10:02, 27 February 2025
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025People also watch
Still looking for a broker you can trust?
Join the 710,000+ traders worldwide that chose to trade with Capital.com